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Background
The development of treatment guidelines emerged as an
important element so as to standardize treatment and to
provide clinicians with algorithms, which would be able
to carry research findings to the everyday clinical practice.
Materials and Methods
The MEDLINE was searched with the combination of each
one of the key words 'mania', 'manic', 'bipolar', 'manic-
depression', 'manic-depressive' with 'treatment guide-
lines'.
Results
The search was updated until March 1st, 2004 and
returned 224 articles. Twenty seven papers concerning the
publication of treatment algorithms were traced.
Discussion
Despite supposedly being evidence-based, guidelines for
the treatment of bipolar disorder vary significantly across
committees or working groups. Overall, however, at the
first stage of the mania/hypomania algorithm, mono-
therapy with lithium, divalproex sodium or olanzapine is
generally recommended. At latter stages combination
therapy is strongly recommended. It is clearly stated that
in bipolar depression antidepressants should be used only
in combination with antimanic agents in order to avoid
switching of phases. During the maintenance phase all
patients should receive antimanic agents, while some may
need the addition of antidepressants. The most recent
guidelines emphasize the use of atypical antipsychotics
for mania and lamotrigine for depression. The main prob-
lem with guidelines is that they are rapidly outdated and
that the evidence base relies mainly on registration mon-
otherapy trials that hardly reflect treatment in routine
clinical conditions.
Conclusion
Treatment guidelines may be useful to avoid non-evi-
dence-based treatment decisions, but they are quickly out-
of-date and may not fully apply to the clinical setting. The
more recent guidelines point the value of atypical antipsy-
chotics, lithium, and valproate in the treatment of mania;
the role of lithium, lamotigine and olanzapine as options
for maintenance therapy; and the scarcity of options for
the treatment of bipolar depression. Psychoeducation is
also supported by most guidelines as an adjunctive treat-
ment.
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